Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy

Okan Safak; Shenghan Wang; Carmen Mota Reyes; Ibrahim Halil Gürcinar; Sergey Tokalov; Nedim Can Cevik; Kivanc Görgülü; Bengi Su Yilmaz; Emre Erdogan; Linhan Ye; Qiaolin Li; Elif Arik Sever; Samed Özer; Güldal Süyen; Helmut Friess; Güralp Onur Ceyhan; Rouzanna Istvanffy; Hana Algül; Ihsan Ekin Demir

doi:10.1002/cac2.12496

Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy

Okan Safak, Shenghan Wang, Carmen Mota Reyes, Ibrahim Halil Gürcinar, Sergey Tokalov, Nedim Can Cevik, Kivanc Görgülü, Bengi Su Yilmaz, Emre Erdogan, Linhan Ye, Qiaolin Li, Elif Arik Sever, Samed Özer, Güldal Süyen, Helmut Friess, Güralp Onur Ceyhan, Rouzanna Istvanffy, Hana Algül, Ihsan Ekin Demir

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	178-182
Seitenumfang	5
Fachzeitschrift	Cancer Communications
Jahrgang	44
Ausgabenummer	1
DOIs	https://doi.org/10.1002/cac2.12496
Publikationsstatus	Veröffentlicht - Jan. 2024
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1002/cac2.12496

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Safak, O., Wang, S., Mota Reyes, C., Gürcinar, I. H., Tokalov, S., Cevik, N. C., Görgülü, K., Yilmaz, B. S., Erdogan, E., Ye, L., Li, Q., Sever, E. A., Özer, S., Süyen, G., Friess, H., Ceyhan, G. O., Istvanffy, R., Algül, H., & Demir, I. E. (2024). Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy. Cancer Communications, 44(1), 178-182. https://doi.org/10.1002/cac2.12496

@article{f9b5550c74854bd5a7f5cff702c480bb,

title = "Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy",

author = "Okan Safak and Shenghan Wang and {Mota Reyes}, Carmen and G{\"u}rcinar, {Ibrahim Halil} and Sergey Tokalov and Cevik, {Nedim Can} and Kivanc G{\"o}rg{\"u}l{\"u} and Yilmaz, {Bengi Su} and Emre Erdogan and Linhan Ye and Qiaolin Li and Sever, {Elif Arik} and Samed {\"O}zer and G{\"u}ldal S{\"u}yen and Helmut Friess and Ceyhan, {G{\"u}ralp Onur} and Rouzanna Istvanffy and Hana Alg{\"u}l and Demir, {Ihsan Ekin}",

year = "2024",

month = jan,

doi = "10.1002/cac2.12496",

language = "English",

volume = "44",

pages = "178--182",

journal = "Cancer Communications",

issn = "2523-3548",

publisher = "John Wiley & Sons Inc.",

number = "1",

}

Safak, O, Wang, S, Mota Reyes, C, Gürcinar, IH, Tokalov, S, Cevik, NC, Görgülü, K, Yilmaz, BS, Erdogan, E, Ye, L, Li, Q, Sever, EA, Özer, S, Süyen, G, Friess, H, Ceyhan, GO, Istvanffy, R, Algül, H & Demir, IE 2024, 'Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy', Cancer Communications, Jg. 44, Nr. 1, S. 178-182. https://doi.org/10.1002/cac2.12496

TY - JOUR

T1 - Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy

AU - Safak, Okan

AU - Wang, Shenghan

AU - Mota Reyes, Carmen

AU - Gürcinar, Ibrahim Halil

AU - Tokalov, Sergey

AU - Cevik, Nedim Can

AU - Görgülü, Kivanc

AU - Yilmaz, Bengi Su

AU - Erdogan, Emre

AU - Ye, Linhan

AU - Li, Qiaolin

AU - Sever, Elif Arik

AU - Özer, Samed

AU - Süyen, Güldal

AU - Friess, Helmut

AU - Ceyhan, Güralp Onur

AU - Istvanffy, Rouzanna

AU - Algül, Hana

AU - Demir, Ihsan Ekin

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85174569522&partnerID=8YFLogxK

U2 - 10.1002/cac2.12496

DO - 10.1002/cac2.12496

M3 - Letter

AN - SCOPUS:85174569522

SN - 2523-3548

VL - 44

SP - 178

EP - 182

JO - Cancer Communications

JF - Cancer Communications

IS - 1

ER -